CLS CELESTICA INC revenue, earnings and financials
For the quarter ended September 30, 2026, CELESTICA INC reported revenue of $5.83B (up 82.5% from a year earlier), net income of $397M and diluted EPS of $3.26; over the last four quarters revenue was $18.2B and net income $1.25B; for the fiscal year ended December 2025 revenue was $12.4B, up 28.5% on the year before.
CLS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $12.4B, gross profit $1.49B, operating income $1.04B, net income $833M (margin 6.7%), EPS $7.16
- Fiscal year ended Dec 2024: revenue $9.65B, gross profit $1.03B, operating income $599M, net income $428M (margin 4.4%), EPS $3.61
- Fiscal year ended Dec 2023: revenue $7.96B, gross profit $754M, operating income $338M, net income $244M (margin 3.1%), EPS $2.03
- Fiscal year ended Dec 2022: revenue $7.25B, gross profit $650M, operating income $289M, net income $180M (margin 2.5%), EPS $1.46
CLS quarterly revenue and earnings
- Quarter ended Sep 30, 2026: revenue $5.83B (up 82.5% year over year), net income $397M, EPS $3.26
- Quarter ended Jun 30, 2026: revenue $4.70B (up 62.4% year over year), net income $369M, EPS $3.17
- Quarter ended Mar 31, 2026: revenue $4.05B (up 52.8% year over year), net income $212M, EPS $1.83
- Quarter ended Dec 31, 2025 (from the annual report): revenue $3.65B (up 43.6% year over year), net income $268M, EPS $2.29
- Quarter ended Sep 30, 2025: revenue $3.19B (up 27.8% year over year), net income $268M, EPS $2.31
- Quarter ended Jun 30, 2025: revenue $2.89B (up 21.0% year over year), net income $211M, EPS $1.82
- Quarter ended Mar 31, 2025: revenue $2.65B (up 19.9% year over year), net income $86.2M, EPS $0.74
- Quarter ended Dec 31, 2024 (from the annual report): revenue $2.55B, net income $152M, EPS $1.29
- Quarter ended Sep 30, 2024: revenue $2.50B, net income $89.5M, EPS $0.75
- Quarter ended Jun 30, 2024: revenue $2.39B, net income $95.0M, EPS $0.80
- Quarter ended Mar 31, 2024: revenue $2.21B, net income $91.8M, EPS $0.77
CLS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $660M, share buybacks $153M
- Fiscal year ended Dec 2024: operating cash flow $474M, share buybacks $152M
- Fiscal year ended Dec 2023: operating cash flow $326M, share buybacks $35.6M
- Fiscal year ended Dec 2022: operating cash flow $211M, share buybacks $34.6M
CLS balance sheet
- Sep 30, 2026: cash $3.96B, total assets $15.1B, total liabilities $8.92B, shareholders' equity $6.21B
- Jun 30, 2026: cash $536M, total assets $9.79B, total liabilities $7.31B, shareholders' equity $2.48B
- Mar 31, 2026: cash $378M, total assets $8.26B, total liabilities $6.16B, shareholders' equity $2.10B
- Dec 31, 2025: cash $596M, total assets $7.21B, total liabilities $5.00B, shareholders' equity $2.22B
- Sep 30, 2025: cash $306M, total assets $6.61B, total liabilities $4.58B, shareholders' equity $2.03B
- Jun 30, 2025: cash $314M, total assets $6.24B, total liabilities $4.48B, shareholders' equity $1.76B
- Mar 31, 2025: cash $303M, total assets $5.83B, total liabilities $4.28B, shareholders' equity $1.56B
- Dec 31, 2024: cash $423M, total assets $5.99B, total liabilities $4.09B, shareholders' equity $1.90B
What is CLS's revenue?
CELESTICA INC reported $18.2B of revenue over its last four quarters, through September 30, 2026.
Is CLS profitable?
Yes. CELESTICA INC earned $1.25B over the last four quarters.
What is CLS's EPS?
Diluted earnings per share over the last four quarters were $10.55; $3.26 in the latest quarter.